Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
about
Quantifying the RR of harm to self and others from substance misuse: results from a survey of clinical experts across ScotlandThe designer methcathinone analogs, mephedrone and methylone, are substrates for monoamine transporters in brain tissueMephedrone, compared with MDMA (ecstasy) and amphetamine, rapidly increases both dopamine and 5-HT levels in nucleus accumbens of awake ratsHere today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazinesCathinone neurotoxicity ("The "3Ms")The toxicology of bath salts: a review of synthetic cathinonesNPS: Medical Consequences Associated with Their IntakeMephedrone in adolescent rats: residual memory impairment and acute but not lasting 5-HT depletionDose and time-dependent selective neurotoxicity induced by mephedrone in miceThe preclinical pharmacology of mephedrone; not just MDMA by another name.Using poisons information service data to assess the acute harms associated with novel psychoactive substances.Emerging drugs of abuse: current perspectives on substituted cathinones.Understanding how data triangulation identifies acute toxicity of novel psychoactive drugs.Acute Methylenedioxypyrovalerone Toxicity.Seizures and hyponatremia related to ethcathinone and methylone poisoning."Bath salts" and "plant food" products: the experience of one regional US poison center.Acute kidney injury requiring haemodialysis following ingestion of mephedrone.Acute khat use reduces response conflict in habitual users.Sensitization to the locomotor stimulant effects of "bath salt" constituents, 4-methylmethcathinone (4-MMC) and 3,4-methylenedioxypyrovalerone (MDPV), in male Sprague-Dawley rats.Synthetic cathinone abusePhase I metabolites of mephedrone display biological activity as substrates at monoamine transporters.Cathinone derivatives: a review of their chemistry, pharmacology and toxicology.Neuropathology of substance use disorders.Synthetic cathinones ("bath salts")."Spice," "kryptonite," "black mamba": an overview of brand names and marketing strategies of novel psychoactive substances on the web.Synthetic cathinones in Southern Germany - characteristics of users, substance-patterns, co-ingestions, and complications.Pharmacology should be at the centre of all preclinical and clinical studies on new psychoactive substances (recreational drugs).Differential effects of cathinone compounds and MDMA on body temperature in the rat, and pharmacological characterization of mephedrone-induced hypothermia.Novel Psychoactive Substances-Recent Progress on Neuropharmacological Mechanisms of Action for Selected Drugs.Human Pharmacology of Mephedrone in Comparison with MDMA.Sympathomimetic toxicity in a case of analytically confirmed recreational use of naphyrone (naphthylpyrovalerone).Urinary retention secondary to mephedrone.'Smoking' mephedrone: the identification of the pyrolysis products of 4-methylmethcathinone hydrochloride.Beta-blocker and antipsychotic treatment of toxicity from so-called designer drugs.An Internet Study of User's Experiences of the Synthetic Cathinone 4-Methylethcathinone (4-MEC).Mephedrone-induced uvulitis.Khat use is associated with increased response conflict in humans.Screening of stimulants including designer drugs in urine using a liquid chromatography tandem mass spectrometry system.Mephedrone (4-methylmethcathinone, 'meow'): acute behavioural effects and distribution of Fos expression in adolescent rats.Synthetic Cathinone Exposures Reported to Texas Poison Centers
P2860
Q22242056-6C9C6B6C-815B-44B5-8399-73B931EAD58CQ24615008-9FE2A852-05E6-45D3-B054-F5FAE525B22EQ24617723-9DC9C906-8D9A-498D-955A-6258B79CF3F4Q24631675-5BA6E5DE-1199-4E91-9F2A-C6DB0AE644E5Q26828641-97BD95AC-D88D-4BAD-B7BE-39272638067FQ28253719-5374A2C4-0528-4793-9F03-BBA6B4A18244Q28276182-FBC78591-D9C7-4CF7-B4D7-25E9EE2A17A0Q28483841-33AC03C8-274C-4355-B1D0-744C6EC6E1F4Q28539324-E64FF52F-9199-44DF-8DC6-53111AC5D045Q30412911-C99847F3-38C6-44AB-9B27-F6E87132D531Q30821795-E95506A2-D29A-4BBF-9B0D-98C2B9B8A959Q33706892-FC99064B-E0DC-4479-AD00-25CC3BB9CA9BQ34267407-1D55104A-D40C-42C2-A10D-E4A11C75ACC5Q35749136-DB08CD9A-215F-4060-BEF6-E0B4400AB414Q36548921-7B7FEF29-02F5-4810-AD16-50A676B0EFA7Q36621870-11F291D2-1AD4-4F2F-84F2-3F8B7F8CF024Q36745955-D49F3C82-4F03-4306-BB99-CFABA67472F6Q36939774-FC83BB00-77B2-476E-8D29-23796B32A8F5Q36986325-A0DEADB0-BE0B-4153-8215-EF78A6B39C42Q36996570-17424071-6D3E-405E-8D7F-5305EE9D5C43Q37161370-B28136F9-DCFC-46CD-8D96-7344B2BCAA74Q37900939-A6B14949-6AE8-47EA-8926-B9FFED5A7EB3Q38167646-EEF21457-2DA7-4E6D-90D6-EE08BE56B0A6Q38190773-A2BC72B1-9CA2-4121-92A6-1A2C0A5BD366Q38246079-68E219E5-6A0D-41C9-8757-95CE785E2168Q38873513-02194D17-6028-4D1C-A71C-E621EC0637BCQ39221467-60D78A43-80F5-4602-AC92-71F14CFD6B4BQ39970850-79F4BF08-6F2B-464E-98F0-41D25DCA5E3CQ41462770-EDAA8319-4447-4C03-AEFB-10DF25F707D0Q41654819-56255EE1-661E-446F-A3D7-FC81DCB3AC40Q42730843-7817CF4F-8559-4B53-929C-248143B6556EQ43222915-383FD479-AD71-4E19-B2CE-2B7E199B96ACQ45884398-CB7BB449-124A-417E-B218-D70421273B60Q46114958-6902919D-E727-412A-8111-5C8C6EB8ECB9Q47585671-48DBA3BA-DE62-4FCF-9D98-8C1196D731D2Q47922643-8BCAB997-5FF7-4C6B-BAFE-D545A3AFC990Q47989803-3A371C7D-B01D-49ED-8431-6B4F020CFDBDQ48099182-54916884-843E-426B-941B-57505A788242Q48844071-9192E65D-03AA-4353-B43F-1E447649930AQ58145498-9EBC37F5-6E33-42D8-8D7C-1AC9A982BE04
P2860
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
description
2010 nî lūn-bûn
@nan
2010 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@ast
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@en
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@nl
type
label
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@ast
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@en
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@nl
prefLabel
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@ast
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@en
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone.
@nl
P356
P1476
Clinical pattern of toxicity associated with the novel synthetic cathinone mephedrone
@en
P2093
P I Dargan
S L Greene
P304
P356
10.1136/EMJ.2010.092288
P407
P50
P577
2010-06-26T00:00:00Z